MD Anderson League City

Nassau Bay, Texas 77058

1 studies enrolling now · 10 studies all time

What they study most

Advanced Malignant Solid Neoplasm, Atypical Endometrial Hyperplasia, Breast Adenocarcinoma, Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified, Estrogen Receptor Negative, Estrogen Receptor Positive, Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, HER2/Neu Negative, HER2/Neu Positive, Inflammatory Breast Carcinoma

Studies at this site

• Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer — Recruiting now
• Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Completed
• Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor — Running, not enrolling
• Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery — Running, not enrolling
• Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer — Running, not enrolling
• DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer — Running, not enrolling
• Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer — Stopped early
• Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer — Running, not enrolling
• Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer — Completed
• Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients — Completed